Gufic Biosciences Limited (NSE:GUFICBIO)
India flag India · Delayed Price · Currency is INR
383.65
+22.60 (6.26%)
Apr 24, 2025, 3:29 PM IST

Gufic Biosciences Company Description

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally.

It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals.

The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments.

In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products.

It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.

Gufic Biosciences Limited
Country India
Founded 1970
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,491
CEO Pranav Choksi

Contact Details

Address:
S.M. House
Mumbai, Maharashtra 400057
India
Phone 91 22 6726 1000
Website gufic.com

Stock Details

Ticker Symbol GUFICBIO
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE742B01025
SIC Code 2834

Key Executives

Name Position
Pranav Jayesh Choksi Chief Executive Officer and Whole Time Director
Jayesh Pannalal Choksi Chairman and MD
Pankaj Jayakumar Gandhi Whole-Time Director
Devkinandan B. Roonghta Chief Financial Officer
Nagesh Yarrabathina Chief Operating Officer
Ami Naresh Shah Company Secretary, Compliance Officer and Legal Manager
Pinak Padhya Associate Vice President - Sales and Marketing
Sunil Desai Head ? Human Resource Department
Ashok Laxman Dev President of Operation
Shekhar Tarabir Aley Senior Vice President - Critical Care SBUs, Nepal and Institution